Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Jun;18(4):320-323.
doi: 10.1111/pedi.12512. Epub 2017 Mar 20.

A CACNA1D Mutation in a Patient With Persistent Hyperinsulinaemic Hypoglycaemia, Heart Defects, and Severe Hypotonia

Free PMC article
Case Reports

A CACNA1D Mutation in a Patient With Persistent Hyperinsulinaemic Hypoglycaemia, Heart Defects, and Severe Hypotonia

S E Flanagan et al. Pediatr Diabetes. .
Free PMC article


Congenital hyperinsulinaemic hypoglycaemia (HH) can occur in isolation or it may present as part of a wider syndrome. For approximately 40%-50% of individuals with this condition, sequence analysis of the known HH genes identifies a causative mutation. Identifying the underlying genetic aetiology in the remaining cases is important as a genetic diagnosis will inform on recurrence risk, may guide medical management and will provide valuable insights into β-cell physiology. We sequenced the exome of a child with persistent diazoxide-responsive HH, mild aortic insufficiency, severe hypotonia, and developmental delay as well as the unaffected parents. This analysis identified a de novo mutation, p.G403D, in the proband's CACNA1D gene. CACNA1D encodes the main L-type voltage-gated calcium channel in the pancreatic β-cell, a key component of the insulin secretion pathway. The p.G403D mutation had been reported previously as an activating mutation in an individual with primary hyper-aldosteronism, neuromuscular abnormalities, and transient hypoglycaemia. Sequence analysis of the CACNA1D gene in 60 further cases with HH did not identify a pathogenic mutation. Identification of an activating CACNA1D mutation in a second patient with congenital HH confirms the aetiological role of CACNA1D mutations in this disorder. A genetic diagnosis is important as treatment with a calcium channel blocker may be an option for the medical management of this patient.

Keywords: CACNA1D; calcium channel; exome sequencing; hyperinsulinism; hypoglycaemia.


Figure 1
Figure 1
A, An integrative genomics viewer (IGV) screenshot showing the sequencing reads (grey bars) mapping to exon 8 of the CACNA1D gene located at genomic position g.53,673,804 on chromosome 3. The reference nucleotide sequence and the amino acid translation are provided under the sequencing reads. The heterozygous substitution of a guanine (G) to an adenine (A) at nucleotide position 1208 in 8 of the 18 sequencing reads is highlighted in green. B, The Sanger sequencing trace for the variant. The top trace is the reference while the bottom is the patient's sample. The heterozygous substitution of a guanine (G) to an adenine (A) is highlighted.

Similar articles

See all similar articles

Cited by 19 articles

See all "Cited by" articles


    1. Eichmann D, Hufnagel M, Quick P, Santer R. Treatment of hyperinsulinaemic hypoglycaemia with nifedipine. Eur J Pediatr. 1999;158:204‐206. - PubMed
    1. Rozenkova K, Guemes M, Shah P, Hussain K. The diagnosis and management of hyperinsulinaemic hypoglycaemia. J Clin Res Pediatr Endocrinol. 2015;7:86‐97. - PMC - PubMed
    1. Kapoor RR, Flanagan SE, Arya VB, Shield JP, Ellard S, Hussain K. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol. 2013;168:557‐564. - PMC - PubMed
    1. Kapoor RR, James C, Hussain K. Hyperinsulinism in developmental syndromes. Endocr Dev. 2009;14:95‐113. - PubMed
    1. Flanagan SE, Haapaniemi E, Russell MA, et al. Activating germline mutations in STAT3 cause early‐onset multi‐organ autoimmune disease. Nat Genet. 2014;46:812‐814. - PMC - PubMed

Publication types

MeSH terms